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ABSTRACT
ZNF143 is a zinc-finger protein involved in the tran-
scriptional regulation of both coding and non-
coding genes from polymerase II and III promoters.
Our study deciphers the genome-wide regulatory
role of ZNF143 in relation with the two previously
unrelated transcription factors Notch1/ICN1 and
thanatos-associated protein 11 (THAP11) in several
human and murine cells. We show that two distinct
motifs, SBS1 and SBS2, are associated to ZNF143-
binding events in promoters of >3000 genes.
Without co-occupation, these sites are also bound
by Notch1/ICN1 in T-lymphoblastic leukaemia cells
as well as by THAP11, a factor involved in
self-renewal of embryonic stem cells. We present
evidence that ICN1 binding overlaps with ZNF143
binding events at the SBS1 and SBS2 motifs,
whereas the overlap occurs only at SBS2 for
THAP11. We demonstrate that the three factors
modulate expression of common target genes
through the mutually exclusive occupation of over-
lapping binding sites. The model we propose
predicts that the binding competition between the
three factors controls biological processes such
as rapid cell growth of both neoplastic and stem
cells. Overall, our study establishes a novel relation-
ship between ZNF143, THAP11 and ICN1 and reveals
important insights into ZNF143-mediated gene
regulation.
INTRODUCTION
The transcriptional regulatory system plays a fundamental
role in controlling the correct expression of genes involved
in many biological processes (1). This mechanism involves
speciﬁc DNA-binding transcription factors, co-factors
and chromatin remodelling factors. In humans, there are
nearly 1400 transcription factors of which only a few have
been extensively studied (1). They bind to cis-regulatory
elements located in the promoters of speciﬁc genes and
modulate their activation or repression (2). Therefore,
their inﬂuence on gene expression is achieved by acting
directly, or via a multiplicity of partners, on chromatin
remodelling and recruitment of the transcription machin-
ery (3). Despite our limited knowledge of the function of
all transcription factors, cis-regulatory regions of genes
are broadly studied nowadays at the genome-wide scale
(4). Owing to the increasing number of high-throughput
studies (5,6), numerous transcription factors are found to
be located within the same promoter regions affecting or
not the gene expression, acting in synergy or having an-
tagonistic effects depending on physiological and environ-
mental conditions (7,8). Thereby combinatorial binding of
transcription factors modulates gene expression according
to the needs and conditions of cells (9).
In this regard, we were ﬁrst interested in deciphering the
genome-wide regulatory potential of the transcription
factor ZNF143. Also known as Staf (Seleno cysteine
tRNA gene transcription activating factor), it is a
zinc-ﬁnger protein involved in the control of both
coding and non-coding genes from RNA polymerase II
(Pol II) and RNA polymerase III (Pol III) promoters
(10). This factor recognizes and binds with high afﬁnity
a well-characterized 18-bp motif located in the core
promoter region. ZNF143 has been shown to be
involved in the activation of several ncRNA (10–12) and
protein-coding genes (13–15). It is conserved in all chord-
ates, and its vertebrate paralogue ZNF76 (16) possesses an
identical central 209 amino acid long DNA-binding
domain (DBD). ZNF143 is involved in the resistance to
cis-platin in cancer cells through the transcriptional regu-
lation of DNA repair genes (17). Moreover, this factor is
critical for the normal development of zebraﬁsh embryo
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(18). ZNF143 and Zfp143, the murine orthologue, are im-
portant for the maintenance of pluripotency of embryonic
stem cells (19,20). Considering this evidence, it is likely
that ZNF143 plays a role in the regulation of gene expres-
sion in rapidly growing cells.
ICN1 is the active form of the Notch1 receptor, which
activates transcription of target genes through binding to
the DNA-binding repressor RBPJ (21). In the canonical
Notch1 pathway, after binding of the ligand (DELTA and
JAGGED family members), the Notch1 receptor is
cleaved through highly regulated step-wise processes
carried out by the g-secretase (21,22). The released active
intracellular form ICN1 enters the nucleus and forms a
transcriptional complex with RBPJ that recognizes a
7-bp motif TTCCCAA on the DNA (23). Although the
canonical Notch1 pathway, mediated by cell–to-cell com-
munication, is implicated in diverse developmental biolo-
gical processes (24), the aberrant and increased activity of
Notch1 signalling is present in many human cancers and
implicated in regulating self-renewal of stem cell-like cells
in tumours (22). One of the most notable disorders
mediated by the deregulated Notch1 pathway is the
T-Acute Lymphoblastic Leukaemia (T-ALL), in which
gain-of-function mutations in Notch1 lead to ligand-
independent ICN1 overproduction in leukaemic blasts
(23).
Thanatos-associated protein 11 (THAP11) is a C2CH
zinc-ﬁnger transcription factor, binding speciﬁcally a 15-
bp long bipartite DNA motif (25). This ubiquitous protein
is overexpressed in colon cancer cells (26) and in embry-
onic stem cells (27), where it plays a speciﬁc role in cell
proliferation. Until recently, it was admitted that THAP11
had a repressor function mediated by its co-factor HCF-1
(27). However, it was recently shown that for some genes,
THAP11/HCF1 could act as a transcription activator as
well (25,26). In mouse, Ronin (THAP11 orthologue) is
essential for embryogenesis and the pluripotency of
embryonic stem cells (mES cells) (27). Recent work
showed that Ronin-targeted genes in mouse mES cells
function in protein biosynthesis and energy production,
suggesting a major role in cell growth (25).
In this work, we report the genome-wide association to
DNA of ZNF143, ICN1 and THAP11 transcription
factors in different human and murine cells. Owing to
similarities in target genes and DNA-binding motifs, we
also investigated their regulatory potential by combining
transcriptome analysis with chromatin immunopre-
cipitation followed by high-throughput sequencing
(ChIP-Seq) data. This study presents strong evidence
that the three factors play a pivotal role in modulating
expression of a common set of genes controlling biosyn-
thetic pathways via the mutually exclusive occupancy of
overlapping binding sites.
MATERIALS AND METHODS
Antibodies and constructs
Antibodies and constructs used in these studies are
described in Supplementary Materials and Methods
(Supplementary data).
Generation of stable cell lines and induced protein
expression
Flp-InTM T-RexTM 293 system (Invitrogen) was used ac-
cording to the manufacturer’s instructions to generate
stable cell lines with regulated expression of ZNF143
(FLP143), ZNF143-3xHA (FLP143-HA), ZNF76
(FLP76) RBPJ-3xHA (FLP_RBPJ-HA) and THAP11-
3xHA (FLPTHAP11-HA). Stable clones containing the
required open reading frame under the control of the cyto-
megalovirus/tetO2 hybrid promoter were selected by
culturing in selective medium containing 250 mg/ml of
hygromycin (InvivoGen) and 15 mg/ml of blasticidin
(InvivoGen). Resistant colonies were expanded and
tested for doxycycline-regulated protein expression.
Protein expression was induced by addition of 1 mg/ml of
doxycycline in culture medium.
ChIP and ChIP-Seq
ChIP assays were performed essentially as previously
described (28) with 1–4 107 cells. Chromatin was
sonicated to an average of 200 bp using a BioruptorTM
UCD-200 (Diagenode) at maximum power level for
30min (pulses of 30 s with 30 s breaks). After DNA puri-
ﬁcation, enrichment was estimated by quantitative real
time PCR (qPCR). qPCR was performed in duplicate on
a Stratagene Mx3005P PCR system (Agilent
Technologies) using 5 HOT Pol EvaGreenqPCR
Mix PLUS (ROX) (Euromedex) and input DNA as the
standard. Promoters containing, and regions devoid of the
studied binding sites, were used as positive and negative
controls, respectively. Enrichment was determined by the
Ct method. Primer sequences are available on request.
Samples were sequenced using the Illumina Genome
Analyzer GAII, and the read sequences were mapped to
unmasked version of the human (hg19) or mouse (mm9)
genomes via the Illumina Eland V1.6 (Illumina) or by the
Bowtie software (29) with either an exact 36 nt match or
with a single or two mismatches. Reads mapped to
multiple locations were discarded, and no more than
two redundant reads having exactly the same genomic co-
ordinates were used to identify enriched regions. Tag
mapping in the large families of highly related ncRNA
genes was performed with the Bowtie software, allowing
two perfect matches in the genome. ChIP-Seq data were
submitted to the Gene Expression Omnibus database and
assigned the identiﬁer GSE39263.
Description of ChIP-Seq data processing and integra-
tive analysis is available in Supplementary Materials and
Methods (Supplementary data).
Electrophoretic mobility shift assay
Recombinant ZNF143 DBD, RBPJ from VK91 (30) and
THAP11 DBD were produced using the GST gene fusion
system as previously described (15,30) essentially accord-
ing to the manufacturer’s instructions (GE Healthcare).
Dissociation constants of ZNF143 on the SBS1 (GTTA
TGGAATTCCCATTATGCACCGCG) or SBS2 (AAAC
TACAATTCCCATTATGCACCGCG) motifs were
derived as previously described (16). Internally labelled
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DNA fragments containing the SBS1 (TTCCCATTATG
CACCGCG), SBS2 (ACTACAATTCCCATTATGCAC
CGCG), THAP11-binding site (TBS) (ACTACAATT
CCCA) and ACTACAA motifs were produced by PCR
in the presence of 50 mCi of (a-32P)dCTP (3000Ci/mmol).
Binding assays were performed essentially as described
(15) with 20 fmol of labelled probe. Protein–DNA
complexes were resolved by electrophoresis on 4%
native polyacrylamide gels containing 0.25Tris-borate-
EDTA. Competition was performed with a 200-fold molar
excess of unlabelled speciﬁc competitor or unspeciﬁc
competitor.
RNA preparation and expression analysis
ZNF143 knockdown was performed in HeLa cells as
described previously (28). The THAP11-speciﬁc Mission
esiRNA (Sigma-Aldrich) targeting positions 872–1276 of
the THAP11 mRNA or control, esiRNA targeting GFP
(Sigma-Aldrich) were transfected into HeLa cells using
Lipofectamine2000 according to manufacturer’s instruc-
tions (Invitrogen). For g-secretase inhibition, HPB-ALL
cells were treated with 500 nM of Compound E (Enzo Life
Sciences), and control was obtained with DMSO-treated
HBP-ALL cells. ZNF143-HA or ZNF143 overexpression
was induced by treatment of FLP143-HA or FLP143 cells
with 1 mg/ml of doxycycline, and cells were collected at
different time points post-induction. Total RNA was ex-
tracted using TRIREAGENT (Euromedex) and reverse
transcribed with dN9 oligonucleotides. The complemen-
tary DNA obtained was ampliﬁed with speciﬁc primers
on the Stratagene Mx3005P PCR system (Agilent
Technologies) using EvaGreen qPCR Mix Plus
(Euromedex). Primer sequences are available on request.
All reactions were carried out in triplicate. The relative
expression ratio was calculated using the REST 2009
software (Qiagen).
RNA-seq differential expression analysis
Total RNA was isolated from HeLa-S3 and FLP143 cells
treated as described earlier in the text. After selection of
polyA+mRNA, RNA-seq libraries preparation was per-
formed using Illumina TruSeq RNA Sample Preparation
kit according to manufacturer protocol. All RNA samples
were sequenced using the Illumina Genome Analyzer
GAII and aligned to the hg19 reference genome using
TopHat software (31). Aligned reads were processed
with Cuffdiff (32) to measure the differential expression
using the RefSeq genes as reference annotation. Only the
transcripts matching the genes potentially regulated by
ZNF143 (TSS located at +/2 kb of a ChIP-Seq peak
summit) were analysed, and the expression value for
each transcript was measured by a FPKM value
(Fragments per kilobase of transcripts per million
mapped tags). RNA-seq data were submitted to the
Gene Expression Omnibus database and assigned the
identiﬁer GSE39263.
Data access
Data from this study were submitted to the NCBI Gene
Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo)
under accession number GSE39263.
RESULTS
Genome-wide identiﬁcation, characterization and
distribution of ZNF143-binding events in different
human and mouse cell lines
To identify ZNF143-binding events, ChIP-Seq was per-
formed with anti-ZNF143 antibody in four human
(HeLa-S3, T-REx HEK293, K562 and HPB-ALL;
Supplementary Figure S1A) and three mouse cell types
(NIH3T3, mESC and MEF; Supplementary Figure
S1B). Quantitative enrichment analysis of the ZNF143
peaks showed a strong correlation (coefﬁcient between
0.77 and 0.93) between the experiments (Figure 1A and
Supplementary Figure S2). The locations of ZNF143-
binding events show an important enrichment in peaks
located at +/2 kb from the transcription start site
(TSS) of protein coding genes (50 and 59% of all human
and mouse ZNF143-binding events, respectively)
(Supplementary Table S1) (Figure 1B and C and
Supplementary Figure S3A). In human and mouse cells,
we identiﬁed the MLT1J retrotransposon subfamily,
showing a signiﬁcant enrichment in ZNF143 peaks
compared with random coordinates (88.9-fold enrichment
in HeLa cells). MLT1J retroelements associated with
ZNF143 are essentially located outside of promoters and
represent 35.5% of repeat elements overlapping ZNF143-
binding events in HeLa cells (Figure 1D). We will focus
now on ZNF143-binding events located and enriched at
proximity of the TSS of coding genes (+/2 kb from a
TSS) (Supplementary Figure S3B). We identiﬁed, at these
locations, 3122 ZNF143-binding events in the set of
human (Supplementary Table S4) and 3385 in the set of
mouse cells (Supplementary Table S5), 60.3% of which
being conserved in humans (Figure 1E). We observed a
core set of 2504 ZNF143-binding regions shared by the
four human cell lines (Figure 1F) and one of 2686 shared
by the three mouse cell types (data not shown). The
binding events were essentially present in the 500 bp
upstream of the TSS (Supplementary Figure S4) with a
positional preference at 70 bp upstream of it
(Figure 1G). We observed also an important enrichment
of the ZNF143-binding events located in bidirectional
promoters. In human cells, 661 binding events are
located within bidirectional promoters (Supplementary
Table S4), representing 17% of all the bidirectional pro-
moters in the genome. The chromosomal distribution of
the ZNF143-binding events showed a noteworthy enrich-
ment of the ZNF143 peaks in promoters of genes
encoding kru¨ppel-associated box (KRAB) zinc-ﬁnger
proteins on the human chromosome 19 and mouse
chromosome 7 (Supplementary Figure S5). Finally, we
examined the ZNF143 occupancy in ﬁve sets of ncRNA
genes (RefSeq ncRNA, ensembl ncRNA, lincRNA,
TUCP and Pol III ncRNA). We identiﬁed 476
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Figure 1. Genome-wide characterization of ZNF143-binding events in human and mouse cells. (A) Correlation plots of ZNF143-binding events in
four human cell lines. Grid of pairwise scatter plots with associated Pearson correlation coefﬁcient obtained using Cistrome software (33). The blue
dots coordinates represent the normalized enrichments in reads for each cell lines at all the peaks coordinates (Supplementary Table S1). The
regression line is indicated in red and the Pearson correlation coefﬁcients are indicated in the squares on the top right (B) Pie charts showing
distribution of the ZNF143-binding events in different genomic regions. A promoter is deﬁned as a region within 2 kb from the TSS of a gene;
downstream, 2 kb downstream of the end of a gene; the distal intergenic are regions excluding a promoter, downstream, 50UTR, 3’UTR, introns and
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ZNF143-binding events located at+/2 kb from the TSS
of a ncRNA gene belonging to four subsets
(Supplementary Table S6 and Supplementary Figure S6).
Overall, subset 1 includes binding events at proximity of
lincRNA, TUCP and other ncRNA genes. Subset 2
includes binding events at proximity of tRNA, miRNA
and snoRNA/scaRNA genes. The latter two subsets 3
and 4 contain Pol III type 3 ncRNA genes and Pol II
snRNA genes, respectively (Supplementary Table S7).
Two distinct motifs with overlapping sequences are
associated to the in vivo ZNF143-binding events
We identiﬁed by a motif search conducted on all ZNF143-
binding events the known 18-bp ZNF143-binding motif
(10) and a second 25-bp motif containing the ﬁrst one
with an additional ACTACAN sequence located immedi-
ately upstream (Figure 2A). Henceforth, we will refer to
the canonical 18-bp motif as SBS1 and the 25-bp motif as
SBS2 (Figure 2A). The ZNF143-binding events that
overlap MLT1J retroelements contain only the SBS2
motif (Figure 2B). For motifs associated to the ZNF143
peaks identiﬁed at proximity of ncRNA genes, we
determined that the binding events in subsets 1 and 2
(Supplementary Figure S6) include the SBS1 and/or
SBS2 motifs. Surprisingly, all the 56 ZNF143-binding
events associated to Pol III type 3 ncRNA and Pol II
snRNA genes (subsets 3 and 4 in Supplementary Figure
S6) contain only one SBS1 motif while we would expect
only 10 in respect of the distribution of SBS1 and SBS2
motifs in the all binding events (z-test: P< 105). Subset 3
contains peaks located at proximity of the TRNAU1
(tRNASec), RNU6.1, RNU6.2, RNAU6.7-U6.9,
RN7SK, RPPH1, RNY1, RNY3, RNY4 and RNY5
genes (Supplementary Table S7). Supplementary Figure
S7A (lower part) displays a multiple alignment showing
sequences of the four elements (TATA element, PSE
promoter element, octamer motif and SBS1) (35)
constituting the promoters of the 12 genes cited earlier
in the text. The position of the SBS1 motif is restricted
to a window covering positions 245/199, except for the
promoter of the RPPH1 gene (11) where SBS1 is located
at position 87. Subset 4 (Pol II snRNA genes) contains
the RNU1, RNU2, RNU4, RNU4ATAC, RNU5, RNU8,
RNU11 and RNU12 genes (Supplementary Table S7).
The multiple sequence alignment in Supplementary
Figures S7A (upper part) and S7B shows the presence of
canonical PSE and octamer motifs at proximity of SBS1 in
41 of the 44 Pol II snRNA genes (Supplementary Table
S7). We will henceforth focus on the SBS1 and SBS2
motifs identiﬁed in promoters (+/2 kb from a TSS) of
protein coding genes in humans. The SBS1 and/or SBS2
motifs were detected in 74% of the 3122 binding events
(Figure 2C and Supplementary Table S4). As ZNF143
could be targeted to certain locations by some of its
putative partners, we searched for known binding sites
in the peaks without any obvious ZNF143-binding
motif. The only other motif reported was an Sp1-like
binding site; it was enriched around the peaks, reﬂecting
per se the association of ZNF143 with CpG islands.
Figure 2C shows that the family of peaks with SBS1
and/or SBS2 motifs consists of three subfamilies: one sub-
family (32% of all peaks) contains only SBS1 motifs, the
second (23%) only SBS2 motifs and the third one (19%)
both motifs. We observed that 21 and 14% of all binding
events contain only a single SBS1 or SBS2 motif, respect-
ively (Figure 2C). Strikingly, in contrast to the binding
events with only an SBS1 or an increasing number
of SBS1 motif, the ZNF143-binding events with a single
or increasing number of SBS2 motifs showed a
increasing ChIP score (t-test: P< 105) (Figure 2D and
Supplementary Figure S8) Finally, we examined the func-
tional annotation of genes at proximity of the 2504 core
set of ZNF143-binding events shared by the four human
cell lines (Figure 3A). We compared then four sets of genes
identiﬁed at proximity of the peaks and containing differ-
ent combinations of motifs (SBS1 motif only, SBS2 motif
only, both motifs) or without motif (Supplementary
Figure S9). Overall, the functional analysis revealed that
all the sets of genes are enriched in terms associated to cell
growth and primary metabolism. Nevertheless, a high en-
richment score was found for terms such as translation for
the set of genes associated to SBS1 and transcription regu-
lation and zinc ﬁngers for the SBS2 motif. To attest the
involvement of ZNF143 in cell growth and primary me-
tabolism, we tested the impact of ZNF143 knockdown on
HeLa-S3 cells proliferation. As expected and as previously
shown for PC3 cells (37), HeLa-S3 cells had a signiﬁcantly
reduced proliferation rate at 72 h post-transfection with
siRNA targeting speciﬁcally ZNF143 versus siRNA-tar-
geting GFP (Figure 3B).
Figure 1. Continued
exons. Distribution of the different genomic regions in the human genome is given as a reference. Analysis was performed using the coordinates of the
peaks summit in HeLa-S3 cells (Supplementary Table S1, P-value threshold of 105) expanded to 400 bp (+/200 bp on both sides of the summit).
(C) Box plots depicting the read enrichment of peaks located in various genomic regions. The peaks and enrichment value (in number of reads) are
from the HeLa-S3 ChIP-Seq experiment. The blue and red box plots correspond to genomic regions located at less and more than 2 kb from a TSS,
respectively. The size of each population of peaks is reﬂected by the width of the plot. (D) Distribution of MLT1J elements in ZNF143 peaks located
inside (+/2 kb from a TSS) and outside of promoters. The random coordinates were generated, 10 times, by random permutation of the set of peak
coordinates located outside promoters across the genome. MLT1J elements are expressed in percentage of MLT1J in repeat elements that overlap
ZNF143-binding events. (E) Venn diagram depicting the overlap of ZNF143-binding events located inside promoters in mouse and human cells,
respectively. The analysis was performed using the complete data set listed in Supplementary Tables S4 and S5 with coordinate conversion from mm9
to hg19. (F) Venn diagram showing the overlap between the ZNF143-binding events identiﬁed at+/2 kb from a TSS (Supplementary Table S4) in
HeLa-S3, K562, 293T-Rex and HPB-ALL human cells. (G) Positional preference of the ZNF143-binding events in promoters. Average proﬁle of the
3122 human ZNF143-binding events (Supplementary Table S4) located at+/2 kb from a TSS. Positions are given in nucleotides (nt), and negative
values correspond to locations upstream from the TSS. (H) Comparison between all the ZNF143- and ZNF76-binding events identiﬁed by ChIP-Seq
in stable cell lines expressing ZNF143-HA or ZNF76. The scatter plot represents the enrichment correlation of both experiments (Supplementary
Table S1). Scale represents normalized number of reads.
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Genome-wide analysis of ZNF76 binding in
T-REx HEK293 cells reveals a total overlap
with ZNF143 binding
In mammalian cells, ZNF76 was characterized as the
ZNF143 paralogue with an activator and repressor
function (16,38). We asked whether the identiﬁed
ZNF143 targets are recognized by ZNF76 in human
T-Rex-HEK293 cells expressing ZNF76 (Supplementary
Figure S1D). To facilitate ChIP, clonal cell lines express-
ing ZNF76 were generated (Supplementary Figure S1A),
and we characterized the loci occupied by this factor by
ChIP-Seq. The data were compared with those obtained
by the anti-HA ChIP-Seq on FLP143-HA cells. An enrich-
ment correlation coefﬁcient of 0.94 was observed between
the two experiments for all of the binding events
(Figure 1H). Obviously, a de novo motif search showed
that the ZNF76-binding events include the SBS1 or
SBS2 motifs described earlier in the text. Moreover,
both ZNF76 and ZNF143 behave, in terms of enrichment
on SBS1 or SBS2 sites, in an identical way. This is
illustrated in Supplementary Figure S10 with the peaks
formed on the ATP5J2 (SBS1 only) and NUP153
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Figure 2. Identiﬁcation and characterization of ZNF143-binding motifs. (A) Sequence logo depicting the SBS1 and SBS2 motifs discovered de novo
at+/100 bp ZNF143 peak summits in human and mouse genomes, using the MEME suite (34). (B) Multiple sequence alignment depicting some of
the MLTIJ elements that are bound by ZNF143. Coordinates of the repeated elements are shown on the left with indication of the orientation of the
element (+/). (C) ZNF143-binding event counts in human genome associated with SBS1, SBS2, SBS1 and SBS2, a single SBS1 or a single SBS2
motif. (D) Box blots showing ChIP-Seq score (number of reads) distribution of ZNF143-binding events containing: only SBS1 or SBS2 motifs.
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Figure 3. ZNF143-targeted genes are involved in cell growth and proliferation. (A) Functional categories enriched among the genes located at +/
2 kb of the identiﬁed ZNF143-binding events common to HeLa-S3, K562, T-Rex-293 and HPB-ALL cell line (Supplementary Table S4), as
reported by the DAVID web-based functional annotation program (36). Values are fold-enrichment scores compared with the whole set of
human genes used as background. (B) Cell proliferation assay performed for a 72 h time course on HeLa-S3 cells non-transfected (no siRNA) or
transfected with siRNA-targeting ZNF143 or GFP. Results are expressed as means +/ standard deviation of three biological replicates.
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(SBS2 only) promoters. We evidenced also that ZNF76 is
associated to ncRNA genes with a total overlap with the
ZNF143-binding events.
THAP11 and ZNF143 bind genome-wide to SBS2 sites
through mutually exclusive events
The widespread association of SBS1 and/or SBS2 motifs
to ZNF143-binding events led us to examine whether the
additional ACTACAN sequence in SBS2 affects ZNF143
binding. The apparent Kd of ZNF143 for the SBS1 (1.36
+/0.33 nM) and SBS2 (1.58+/0.19 nM) motifs are very
similar (Supplementary Figure S11), suggesting that the 50
part of the SBS2 motif (ACTACAN), or a more extended
sub-motif, constitutes a binding site for another factor.
In this respect, ChIP-Seq on mES cells revealed that the
transcription factor Thap11 binds with its transcriptional
co-regulator Hcf-1 to the sequence motif ACTACANNT
CCCA (TBS) (Figure 4A) (25), suggesting a possible
overlap of ZNF143 and Thap11 DNA-binding events.
We compared the available ChIP-Seq data of Thap11
and its co-factor Hcf-1 (25) obtained from mES cells
with our ZNF143 ChIP-Seq data obtained from the
same cells. We found that 84.7% of all Thap11 and
75.8% of all Hcf-1-binding events located in promoters
overlap the ZNF143-binding events located at +/2 kb
of a TSS (3385 peaks) (Figure 4B). An individual motif
occurrence search on the 651 peaks, common to the
Thap11- and ZNF143-binding events (Figure 4B),
identiﬁed an SBS2 motif in the whole set of coordinates.
Furthermore, a similar search performed on Hcf-1 peaks
without reported Thap11 binding, showed that 51%
(Figure 4B) of them overlap with ZNF143 and contain
also an SBS2 motif. This suggests that Thap11 could in
fact also bind these SBS2 sites. From these observations, it
appears that Thap11 binding is restricted to loci contain-
ing an SBS2 motif. By ChIP, we asked whether the pro-
moters containing only SBS1 (SBS1 loci) or SBS2 (SBS2
loci) motifs are recognized by THAP11. We generated
clonal cell lines expressing HA-Tagged THAP11
(FLPTHAP11-HA) and by anti-HA ChIP, we examined
and compared the THAP11 and ZNF143 occupancy on
SBS1 and SBS2 loci (Figure 4C). As expected, ChIP-Seq
showed ZNF143 occupancy on the nine SBS1 loci and on
the eight SBS2 loci (Figure 4C, lower part). In contrast,
THAP11 occupancy was restricted to the SBS2 loci
without signiﬁcant occupation of the SBS1 loci
(Figure 4C, upper part). By gel-shift experiments, we
further examined the in vitro binding of ZNF143 and
THAP11 DBDs on TBS, SBS1 and SBS2 motifs. As
expected, the ZNF143-DBD binds speciﬁcally to the
SBS1 and SBS2 motifs (Figure 4D, lanes 1–8) but is
unable to recognize the TBS (Figure 4D, lanes 9 and
10). THAP11–DBD recognized speciﬁcally the TBS
(Figure 4D, lanes 11–14) and the SBS2 motif
(Figure 4D, lanes 15–18), which per se contains a TBS.
Surprisingly, unlike the TBS sub-motif ACTACAA
(Figure 4D, lanes 23–26), the SBS1 motif, which
contains only the 30 part of TBS (TTCCCA) binds specif-
ically the THAP11–DBD (Figure 4D, lanes 19–22). This
observation suggests that THAP11 has a higher afﬁnity to
the 30-part of the TBS (TTCCCAN). Binding assays per-
formed on the SBS2 motif in the presence of
ZNF143-DBD and THAP11–DBD revealed that the
binding of the two proteins is mutually exclusive
(Figure 4D, lanes 27–30). Indeed, the shift observed in
the presence of THAP11 (Figure 4D, lane 29) is not
altered by the presence of ZNF143–DBD (Figure 4D,
lane 30). We also tested in vivo the THAP11 occupancy
by ChIP on loci containing SBS2 motifs after ZNF143
siRNA-mediated knockdown in non-induced or induced
FLPTHAP11-HA cells. The induced expression of
THAP11 increases the occupancy of the factor on the pro-
moters (Figure 4E, left part, compare induced and
non-induced after siCTRL treatment). This phenomenon
is ampliﬁed after THAP11 induction performed on cells
with efﬁcient ZNF143 siRNA-mediated knockdown
(Figure 4E, left part, compare induced and non-induced
after siRNA ZNF143). The efﬁciency of ZNF143 deple-
tion was validated by anti-ZNF143 ChIP qPCR, as
illustrated in Figure 4E (right part) for the AHSA1
promoter.
Finally, we determined the over-represented functional
categories of genes located near loci occupied by both
ZNF143 and Thap11 (36). As for the whole set of pro-
moters recognized by ZNF143, the enriched terms concern
cell growth and primary metabolism, whereas cell sig-
nalling and cell development were under-represented.
The association of ZNF143 to the MLT1J retroelement
via a SBS2 motif suggests a possible association of
THAP11 to the same retroelement. Indeed, we veriﬁed
by anti-HA ChIP-qPCR that THAP11 is also associated
in vivo to an MLT1J retroelement locus (Supplementary
Figure S12A).
Genome-wide analysis of Notch1/ICN1 binding in
HPB-ALL cells reveals widespread overlap with ZNF143
The ICN1 protein, the active form of the Notch1 receptor,
is recruited to promoters by RBPJ, which binds to the TT
CCCAA consensus motif (23) frequently associated to an
ACTACAN motif (39). The striking identity of this
extended motif with SBS2 suggests a possible overlap
between the RBPJ/ICN1 and ZNF143-binding events
(Figure 5A). To test this assumption, we performed a
ChIP-Seq experiment in the HPB-ALL cell line using an
antibody directed against ICN1 (Supplementary Table
S1). The data were compared with the ZNF143-ChIP-
Seq data from the same cells. We identiﬁed that among
the 1886 ZNF143- and 8467 ICN1-binding events located
in promoters (Supplementary Table S1), 91.9% of the
ZNF143-binding events are shared with those of the
ICN1 protein (Figure 5B and Supplementary Figure
S13). On average, the positions of the ICN1 and
ZNF143 co-peaks coincided exactly (Figure 5C), suggest-
ing the recognition of common sites by the two proteins.
We also evidenced, as for ZNF143, that ICN1-binding
events have a higher enrichment signal when associated
to an SBS2 than an SBS1 site (t-test: P< 105)
(Figure 5D). By band shift assay, we showed that RBPJ
binds speciﬁcally to SBS1 and SBS2 motifs, both contain-
ing the TTCCCA RBPJ-binding motif (Figure 5E).
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Surprisingly, we observed that the RBPJ-binding was
more efﬁcient on the SBS2 motif, suggesting the possible
involvement of the ACTACAN motif in recognition.
Band shift assays performed on SBS1 or SBS2 motifs in
the presence of ZNF143 and RBPJ revealed that the
binding of the two proteins is mutually exclusive
(Figure 5F). This observation is also supported by the
results of an in vivo competition assay showing that
over-expression of RBPJ provides a signiﬁcant decrease
of the ZNF143 occupation on target promoters common
to ZNF143 and RBPJ (Figure 5G). Globally, this suggests
that the ZNF143-ICN1 co-peaks observed by ChIP-Seq
did not result from a simultaneous co-occupation of
the DNA by both proteins. Finally, the analysis of
ICN1-ChIP-Seq data also revealed that the MLT1J sub-
family of retroelements alone was signiﬁcantly enriched in
ICN1-binding events (Supplementary Figure S12B).
ZNF143, THAP11 and ICN1 levels directly modulate
expression of common target genes
The overlapping binding pattern of ZNF143, THAP11
and ICN1 led us to examine whether they play a direct
role in the regulation of common target genes. To answer
this question, we analysed the global or partial gene
expression pattern after alteration of the level of the
three factors. First, we performed global proﬁling
of gene expression by RNA-Seq in cells depleted
of or over-expressing ZNF143. Both the ZNF143
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Figure 4. Overlapping of ZNF143 and Thap11 DNA-binding events. (A) Sequence alignment of the TBS, SBS1 and SBS2 motifs. The sequence
indicated in light grey is shared by the three motifs. (B) Venn diagram depicting the overlap of ZNF143/Zfp143-, Thap11- and Hcf1-binding events in
mouse ES cells. The analysis was performed using the complete data set listed in Supplementary Table S5 and published ChIP-Seq data (25).
(C) Histograms depicting the enrichment of genomic regions containing only SBS1 or SBS2 motifs in ChIP samples. ChIP assays with anti-HA
antibody were performed on induced FLP143-HA and FLPTHAP11-HA stable cell lines. Uninduced stable cell lines were used as control.
THAP11-HA data are obtained from ChIP-qPCR experiment, amplifying a promoter region containing the binding site. Primer sequences are
available on request. ZNF143-HA data are obtained from ChIP-Seq experiment, using read number values in regions ampliﬁed by qPCR for
THAP11-HA, expanded to 200 bp. SBS1 sites and SBS2 sites correspond to promoters containing only the SBS1 motif or only the SBS2 motif,
respectively. Fold enrichment in promoters was normalized to control regions located at 2 kb of tested promoters. The gene symbols listed are those
of the genes closest to the tested genomic region. (D) ZNF143 and THAP11 in vitro binding assays on SBS1, SBS2, TBS and TBS sub-motif.
Gel retardation assays were performed with 32P labelled double-stranded fragment containing the indicated motif. The labelled probe was incubated
in the presence (+) or absence () of ZNF143 or THAP11 DBD. The reactions in lanes 3, 7, 13, 17, 22, 25 and 4, 8, 14, 18, 21 were performed in the
presence of an excess of unlabelled speciﬁc (sp.) or unspeciﬁc (unsp.) competitors. The ACTACAA probe corresponds to the 50part of the TBS. Each
lane presented in a single panel of the gel picture was from the same gel and the same exposure of the autoradiogram. (E) Histograms depicting the
enrichment of promoter regions containing SBS2 motifs in ChIP samples. ChIP assays with anti-HA antibody were performed on induced or
non-induced FLPTHAP11-HA stable cell line, transfected with siRNA targeting ZNF143 (siZNF143) or GFP (siCTRL). Control ChIP assays
were performed with non-speciﬁc immunoglobulin G (IgG) and ZNF143 knockdown control with anti-ZNF143 antibodies on cells treated with
siRNA targeting ZNF143. The gene symbols listed are those of the genes closest to the tested genomic region.
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Figure 5. ICN1-binding regions co-localize with the ZNF143-binding events. (A) Sequence alignment of the RBPJ-binding site, SBS1 and SBS2
motifs. (B) Venn diagram depicting the overlap of ZNF143 and ICN1-binding events in HPB-ALL cells. (C) Overlap of ICN1 sites with
ZNF143-binding sites in HPB-ALL cells. Average proﬁle of ICN1 and ZNF143 ChIP-Seq signals around the centre of all overlapping peaks.
(D) Box blots showing ChIP-Seq score (number of reads) distribution of ICN1-binding events associated to SBS1 or SBS2 motifs. (E) RBPJ in vitro
binding assays on SBS1 and SBS2 motifs. Gel retardation assays were performed with 32P labelled double stranded fragment containing the indicated
motif. The labelled probe was incubated in the presence (+) or absence () of RBPJ. Reactions in lanes 3, 7 and 4, 8 were performed in the presence
of an excess of unlabelled speciﬁc (sp.) or unspeciﬁc (unsp.) competitors. The RBPJ–DNA complex is indicated by an arrow, the asterisk denotes an
unrelated product. (F) The binding of RBPJ and ZNF143 is mutually exclusive in vitro. Gel retardation assays were performed with 32P labelled
double-stranded fragment containing the SBS2 motif in the presence (+) or absence () of the indicated proteins. Arrows indicate the RBPJ–DNA
and ZNF143–DNA complexes. (G) The binding of RBPJ and ZNF143 is mutually exclusive in vivo. ZNF143-ChIP-qPCR enrichment analysis on
promoters bound by ZNF143 and Notch1. ZNF143-ChIP was performed on non-induced (ChIP reference) and induced FLP_RBPJ-HA cells
expressing the RBPJ-HA (ChIP over-expression RBPJ) protein. ChIP enrichment was measured by qPCR using speciﬁc primers on promoter
compared with negative regions located at 2 kb. Primers are available on request. A control ChIP was performed using non-speciﬁc IgG antibodies
(ChIP control IgG). The gene symbols listed are those of the genes closest to the tested genomic region.
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siRNA-mediated knockdown and over-expression
efﬁciencies were afﬁrmed at the protein (Figure 6A,
lanes 1–6). After deep RNA sequencing, we examined
the relative expression of the genes located at +/2 kb
from a ZNF143 peak (Supplementary Table S2). The
analysis revealed two major populations of differentially
expressed target genes. The largest population (837 genes),
as expected, was downregulated after ZNF143 knock-
down and broadly upregulated after ZNF143 over-expres-
sion (Figure 6B, left part). The second, smaller population
(386 genes), was unexpectedly upregulated after ZNF143
knockdown and mostly downregulated following its
over-expression (Figure 6B, right part). The general
tendency of the proﬁles suggests that on the full set of
genes, ZNF143 acts mainly as an activator but can also
be involved in the repression of transcription. An inde-
pendent veriﬁcation of the RNA-Seq data by RT-qPCR
on a set of 51 genes activated or repressed after ZNF143
knockdown, recapitulated the majority of the ﬁndings
(Supplementary Figure S14A). The genes positively
regulated by ZNF143 (downregulated after ZNF143
knockdown) are primarily associated with ontology
terms involved in transcription (mainly zinc-ﬁnger DNA-
binding proteins), cell cycle regulation and chromatin or-
ganization (Supplementary Figure S14B, red bars). On the
other hand, the negatively regulated genes (upregulated
after ZNF143 knockdown) were only slightly enriched in
genes involved in transcription processes (Supplementary
Figure S14B, blue bars).
As we found THAP11 and ICN1 associated with
ZNF143-binding motifs, we next analysed by RT-qPCR
the effect of THAP11 and ICN1 knockdown on 51
ZNF143 target genes. After THAP11 knockdown in
HeLa-S3 cells using speciﬁc siRNA (Figure 6D), 28 of
the 51 genes were signiﬁcantly upregulated and 4 of the
51 downregulated, in agreement with the major repressor
function of the factor. After knockdown of ICN1
(Figure 6A, lanes 7–10), by g-secretase inhibitor (GSI)
treatment on HPB-ALL cells, 6 of the 51 genes were sig-
niﬁcantly upregulated and 20 of the 51 downregulated
(Figure 6C). Combining our expression data on this
subset of genes, we observed that both SBS1- or SBS2-
containing genes are generally positively regulated by
ZNF143 and ICN1, but, in contrast, genes carrying only
SBS2 sites are signiﬁcantly upregulated by THAP11
knockdown (Figure 6D). We have noticed the presence
of genes upregulated by both ZNF143 and THAP11
knockdown. This is exempliﬁed by JUN that possesses
an SBS1 site and ALG14 with an SBS2 site in their pro-
moters (Figure 6D). This upregulation suggests a direct or
indirect negative regulation effect mediated by both
factors. Taken together, our results identify a set of
genes that can be differentially regulated by loss or gain
of ZNF143, THAP11 and ICN1 function.
Promoters with associated SBS1 or SBS2 motifs carry
different levels of RNA polymerase II and histone
activation marks
The aforementioned data revealed that SBS1- and SBS2-
mediated modulation of gene expression involves a
competitive binding of different transcription factors on
these motifs. We sought then to understand whether this
differential occupation could be correlated with variations
in Pol II occupancy and various histone H3 methylation
and acetylation marks associated to activation or repres-
sion of transcription. It is well established that in the
promoter of Pol II transcribed genes, the activating
H3K4me3 and H3K27ac marks form two peaks on
either side of the TSS, whereas the H3K36me3 mark ac-
cumulates within the transcribed region (40). Enhancers
are commonly characterized by the presence of both
H3K27ac and H3K4me1 histone marks (41). In contrast,
the repressive marks H3K9me3 and H3K27me3 are
associated to the inactive state of the chromatin (40).
We ﬁrst examined in HeLa-S3 cells the presence of
H3K27ac and H3K4me1 around all ZNF143 peaks:
ZNF143 peaks in promoters (+/2 kb of a TSS) and
ZNF143 peaks outside of promoters (Supplementary
Figure S15). ZNF143 enriched regions outside of
promoters do not co-localize with H3K27ac and
H3K4me1 enhancer marks (Supplementary Figure
S15C). On the contrary, peaks located in promoters are
all highly enriched in ZNF143 and H3K27ac activation
marks (Supplementary Figure S15B). Subsequently, we
examined in HeLa-S3 cells the relation between histone
H3 trimethylation and Pol II occupancy patterns on
the ZNF143-binding events located near TSS. Heat
maps representing the enrichment reveal a broad co-local-
ization of ZNF143, Pol II and H3K4me3 modiﬁcations
(Supplementary Figure S16A). Similarly, the H3K36me3
modiﬁcation is found on the body of the genes associated
to ZNF143-binding events (Supplementary Figure S16B).
In contrast to H3K4me3, there was no detectable
H3K9me3 and H3K27me3 modiﬁcation associated
to ZNF143-binding events (Supplementary Figure
S16A). We observed a differential behaviour of loci
associated to SBS1 or SBS2 motifs with respect to
Pol II, H3K4me3 and H3K36me3 enrichments. Indeed,
in opposition to ZNF143 enrichment (Figure 2D and
Supplementary Figure S16C), the Pol II (Figure 6E),
H3K4me3 (Figure 6F) and H3K36me3 enrichments
(Supplementary Figure S16B) are higher on SBS1 than
on SBS2-associated loci (t-test: P< 105). Furthermore,
the Pol II occupancy proﬁle forms two peaks on each
side of SBS2 loci, whereas a single one is observed for
loci associated to SBS1 (Figure 6E). A similar behaviour
of Pol II and H3K4me3 on SBS1 and SBS2 sites is
observed for two different ChIP-Seq data sets from
K562 and mES cells (Supplementary Figure S16D). The
aforementioned observations suggest a distinct transcrip-
tional control on SBS2 sites owing to the preferential
binding of THAP11 on the SBS2 motif. We tested by
ChIP-qPCR the Pol II occupation on several promoters
containing SBS2 motifs after ZNF143 siRNA-mediated
knockdown associated or not to THAP11 overproduction
(Figure 6G). As expected, the results show a decrease of
Pol II occupancy after ZNF143 knockdown, and the Pol
II deﬁciency is ampliﬁed after THAP11 overexpression
(Figure 6G).
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Figure 6. ZNF143, THAP11 and ICN1 co-regulate the expression of target genes. (A) Western blots showing (i) knockdown of ZNF143 at 72h
post-transfection of HeLa cells with speciﬁc siRNA (lane 3) and siRNA control (lanes 1 and 2); (ii) over-expression of ZNF143 in FLP143 cells at 12h
(lane 5), 24h (lane 6) post-induction, uninduced cells (lane 4); (iii) knockdown of ICN1 at 48h and 72h post- treatment of HPB-ALL cells with 500nM
of GSI (compound E) (lanes 9 and 10), DMSO treated (lane 8) and non-treated cells (lane 7). Tubulin was used as a loading control. (B) Bar chart
depicting the RNA-Seq expression proﬁling of all genes located at+/2kb of a ZNF143 peak summit, after knockdown or over-expression of ZNF143.
In grey and black are represented the fold change of expression 48h after siRNA-mediated knockdown and 24h after induced over-expression of
ZNF143 compared with control, respectively. The genes are ordered decreasingly according their positive or negative fold change expression after
ZNF143 knockdown. (C) Bar chart depicting the relative gene expression ratio determined by RT-qPCR for genes containing SBS1 or SBS2 sites, after
ICN1 and ZNF143 knockdown compared with control. RNA was extracted 72h post-transfection of HeLa-S3 cells with speciﬁc siRNAs targeting
ZNF143 and from HPB-ALL cells 72 h post-treatment with 500nM of GSI (compound E). Values represent the mean +/ SD of two or three
independent experiments normalized to the GAPDH level. The dark grey line corresponds to a 0.5-fold expression ratio (D) Bar chart depicting the
relative gene expression ratio determined by RT-qPCR for genes containing SBS1 or SBS2 sites, after THAP11 and ZNF143 knockdown compared with
control. RNA was extracted 72h post-transfection of HeLa-S3 cells with speciﬁc siRNAs targeting ZNF143 or THAP11. Values represent the mean+/
SD of two or three independent experiments normalized to the GAPDH level. The dark grey line corresponds to a 0.5-fold expression ratio (E) Average
ChIP-Seq proﬁle of Pol II and (F) Average proﬁle of H3K4me3 around the centre of ZNF143-binding events identiﬁed in HeLa cells at+/2kb from a
TSS (Supplementary Table S4). All ZNF143-binding events, binding events containing only SBS1 or only SBS2, are indicated in black, dark grey and
light grey, respectively. (G) RNA Pol II-ChIP-qPCR enrichment analysis on promoters bound by THAP11 and containing SBS2 sites. Pol II-ChIP was
performed on cells treated with control siRNA (siCTRL), knockdown for ZNF143 (siZNF143) or knockdown for ZNF143 and over-expressing
THAP11 (siZNF143+THAP11-HA). ChIP enrichment was measured by qPCR using speciﬁc primers on promoter compared with negative regions
located at 2 kb. Values represent the mean+/ SD of two or three independent experiments normalized to the GAPDH promoter levels. Primers are
available on request. The gene symbols listed are those of the genes closest to the tested genomic region.
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DISCUSSION
In this study, we obtained a set of >3000 genes that may
be subject to a ZNF143-mediated regulation in both
humans and mouse. These genes are globally highly
enriched in terms related to transcription, cell cycle,
RNA processing and translation processes, whereas cell
signalling and cell development were under-represented.
In addition, we observed as reported for PC3 cells (37)
that the ZNF143 knockdown reduces signiﬁcantly the
cell proliferation rate in HeLa cells. These observations
strongly suggest a particular role for this factor in cell
growth regulation. We also report that both activation
and repression of gene expression directed by ZNF143
occur in human cells.
Among the ZNF143 target genes, it is worth mentioning
114 KRAB zinc-ﬁnger transcription factors located in
tandem on human chromosome 19. Considering the
amino acid sequence similarity between the subdomain B
of the KRAB box and the ncRNA transcription activation
motif of ZNF143 (42), it is tempting to speculate that
ZNF143 could originate from an ancient KRAB family
member. A co-evolutionary link exists between retroele-
ments and the presence of tandem zinc-ﬁnger genes (43). If
we take into consideration the SBS2 site embedded in
MLT1J retrotransposons, we can hypothesize that
ZNF143 have diverged into a transcriptional regulator
of more recent genes of the same family, generated by
the successive invasion waves of genomes by KRAB
zinc-ﬁngers (44).
According to our results, ZNF76, the vertebrate
paralog of ZNF143, occupies exactly the same binding
sites as those recognized by ZNF143. We previously
showed that ZNF76 is able to activate transcription
(16), but other results have also identiﬁed ZNF76 as a
transcriptional repressor (38). Having the same DNA-
binding speciﬁcity as ZNF143, ZNF76 could have a dif-
ferent non-redundant function or it could play an auxil-
iary replacement function in particular situations.
As many ZNF143-binding events are located at prox-
imity of ncRNA genes, this raises the question of the func-
tionality of these events in ncRNA gene transcription. For
the ZNF143 occupancy on 12 Pol III type 3 and 44 Pol II
snRNA genes, it is very likely that the factor is involved in
their transcriptional activation. Indeed, as very recently
reported (45), all of these promoters contain the canonical
sequence elements (35) and are bound by their proteins
counterparts (46). Thirteen miRNA genes and a large
number of snoRNA and scaRNA genes, found near
ZNF143-binding events, are located in the ﬁrst exon or
in the ﬁrst intron of coding or non-coding host genes. This
opens the possibility that ZNF143 is involved in the ex-
pression of these ncRNAs by directing expression of the
host gene. This is observed for MIR632, MIR659,
MIR663, MIR933, MIR1292 and MIR3917 for which
the host genes are deregulated in cells depleted or over-
expressing ZNF143.
A major aspect of our study concerns the identiﬁcation
and the functional characterization of the SBS1 (18 bp)
and SBS2 (25 bp) motifs associated to ZNF143-binding
events. The additional ACTACAN sequence found in
SBS2 has already been reported as part of one of the
most represented motifs—the M4 motif—in gene pro-
moters (47) and is not required for ZNF143 binding. It
comes out from our study that the TBS ACTACAATTCC
CAG is always physically linked to an overlapping
ZNF143-binding site at the whole genome scale. We also
evidenced, in vitro as well as in vivo, that the binding of
ZNF143 and THAP11 on the SBS2 motif is mutually ex-
clusive. These observations clearly indicate that the SBS2
subset of ZNF143-binding sites contains the set of TBSs.
Moreover, we also demonstrated that the two proteins are
both involved in the transcriptional regulation of the same
set of genes. This gene expression modulation is achieved
through a mutually exclusive binding on overlapping
binding sites. As the result of the competitive binding of
the two factors and to the main repressor activity of
THAP11 (25), the promoters containing SBS2 sites have
lower Pol II and H3K4/36me3 ChIP-Seq proﬁles.
Nevertheless, unlike Pol II and H3K4me3 marks,
ZNF143 shows a notably higher ChIP-Seq enrichment
on SBS2 sites than on SBS1 sites. This observation
supports the notion that SBS1- and SBS2-containing pro-
moters are in different regulatory contexts.
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Figure 7. A model for modulation of gene expression by ZNF143, THAP11 and ICN1. The model considers single or multiple SBS1 and/or SBS2
motifs (n=0 or n 1) in promoters. ZNF143 activates the expression of genes through both SBS1 and SBS2 sites. THAP11 represses the expression
of genes only through SBS2 sites. Instead, genes that are regularly repressed by RBPJ through SBS1 and SBS2 sites (A) are activated in T-ALL cells
when ICN1 is over-expressed (B).
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The examination of SBS1 and SBS2 sites led us to
consider another overlapping binding event with ICN1.
Indeed, we demonstrated that in the T-lymphoblastic
leukaemia cell line HPB-ALL, the constitutively over-ex-
pressed ICN1 protein is recruited in 27.6% of the ICN1-
binding events via the TTCCCA sequence embedded in
SBS1 and SBS2 motifs. In addition, we demonstrated
that the RBPJ protein, which recruits ICN1, binds
in vitro as well as in vivo to the SBS1 and SBS2 sites in
an exclusive manner in the presence of ZNF143. Another
recent study performed in a different T-lymphoblastic
leukemia cell line (CUTLL1) also highlighted that the
ICN1-binding proﬁle is partially overlapping ZNF143-
binding sites (48). However, the authors of this study
identiﬁed only an SBS2-type site as being bound by
ZNF143. In contrast, our work performed on seven dif-
ferent human and mouse cell types clearly distinguishes
the two motifs SBS1 and SBS2 as bound by ZNF143
and subjected to differential binding by two other unre-
lated transcription factors. As for ZNF143, our ChIP-Seq
data on ICN1 showed higher tag enrichment for peaks
associated to the SBS2 than to the SBS1 sites. This is
consistent with our hypothesis that promoters containing
either the SBS1 or SBS2 site are differently regulated. The
gene expression analysis after GSI treatment in HPB-ALL
cells conﬁrmed the major activation function of ICN1
binding on both SBS1 and SBS2 sites.
We can infer from our results that ZNF143, THAP11
and ICN1/RBPJ are not only involved in a competitive
binding on overlapping sites but are also involved in the
transcriptional activity of adjacent genes. We revealed in
this study that the genes targeted by ZNF143 are mainly
involved in biological processes related to cell growth such
as transcription, translation and cell cycle. Our observa-
tion is consistent with several reports concerning the role
of THAP11 and ICN1. Indeed, the capacity of THAP11
to exert anti-differentiation effects in mES cells was ori-
ginally suggested from THAP11 global dependent tran-
scriptional repression of multiple genes that are either
directly or indirectly involved in differentiation (27). In
contrast, more recent results in mES cells showed that
THAP11 can either activate or repress expression of its
transcriptional target genes, essentially involved in the
growth of embryonic stem cells (26). ICN1 is constitu-
tively over-expressed in acute T-cell lymphoblastic
leukaemia cells where it deregulates genes involved in
cell growth processes (48,49). ZNF143, as shown in this
study, is also involved in the regulation of genes involved
in cell growth and has been shown to be important to
maintain the undifferentiated state of mES cells (19).
Taken together, it appears that ZNF143, THAP11 and
ICN1 could together be important for the transcriptional
modulation of genes involved in the proliferation of
rapidly dividing cells, like cancer cells and embryonic
stem cells. Therefore, this control is exerted via a competi-
tive binding on overlapping binding sites.
All the observations and results taken together led us to
propose the following model (Figure 7). The competitive
and combinational binding of ZNF143, THAP11 and
RBPJ/ICN1 on single or multiple SBS1 and SBS2 sites
in promoters is directly involved in the transcriptional
regulation of target genes. This is achieved by activation
via ZNF143 and repression via THAP11 and RBPJ.
Moreover, in HPB-ALL cells, the over-expressed ICN1
recruited by the repressor RBPJ competes for activation
either with ZNF143 on SBS1 motifs or with THAP11 and
ZNF143 on SBS2 motifs (Figure 7). Nevertheless, our
model is restricted to certain genes being activated by
ZNF143 and repressed by THAP11. Other genes, such
as ALG14 and JUN, are negatively regulated by both
THAP11 and ZNF143. This suggests an additional modu-
lation mechanism that involves probably other partners
acting positively or negatively on transcription. Such an
additional partner could be ZNF76 that binds exactly the
same motif as ZNF143. This extra layer of complexity
should be further investigated.
Another interesting outcome of this work concerns
the evolutionary history of SBS2 sites. As shown for
several transcription factors (50), it emerged from our
data that the very ancient family of MLT1J retro-
transposons could be at the origin of the SBS2 sites.
Furthermore, a correlation exists between KRAB zinc-
ﬁnger gene expansions and retro-transposition waves
(43). We thus speculate that ZNF143 originated from an
ancient KRAB zinc-ﬁnger transcription factor family tar-
geting at the time still active MLT1J retro-transposons. In
the course of evolution, these events could have caused
expansion of the repertoire of ZNF143, THAP11 and
ICN1 regulated genes by spreading out the SBS2 sites in
promoter regions.
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